TORONTO – Madi Vanstone, the young girl who suffers from a rare form of cystic fibrosis, will have her drug treatment covered by government health insurance.
Beth Vanstone, Madi’s mother, confirmed to Global News Friday she received a call from the ministry of health earlier in the day to let her know the drug treatment, Kalydeco, will be covered by OHIP.
The drug treatment costs approximately $300,000 each year.
The Vanstone family had been paying for the drug with the help of donations and had urged Premier Kathleen Wynne to find a way for the drug to be covered by OHIP.
Vertex Pharmaceuticals Inc. – the company that manufactures the drug – recently reached a deal with several provinces that enabled provincial health insurance to cover the cost.
Vertex says about 100 Canadians with cystic fibrosis are candidates for Kalydeco.
- Invasive strep: ‘Don’t wait’ to seek care, N.S. woman warns on long road to recovery
- Canadian man dies during Texas Ironman event. His widow wants answers as to why
- ‘Super lice’ are becoming more resistant to chemical shampoos. What to use instead
- Solar eclipse eye damage: More than 160 cases reported in Ontario, Quebec
Comments